Cargando…
FUS/TLS Is a Co-Activator of Androgen Receptor in Prostate Cancer Cells
Androgen receptor (AR) is a member of the nuclear receptor family of transcription factors. Upon binding to androgens, AR becomes transcriptionally active to regulate the expression of target genes that harbor androgen response elements (AREs) in their promoters and/or enhancers. AR is essential for...
Autores principales: | Haile, Simon, Lal, Aaron, Myung, Jae-Kyung, Sadar, Marianne D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164714/ https://www.ncbi.nlm.nih.gov/pubmed/21909421 http://dx.doi.org/10.1371/journal.pone.0024197 |
Ejemplares similares
-
TLS/FUS: A protein in cancer and ALS
por: Tan, Adelene Y., et al.
Publicado: (2012) -
A Yeast Model of FUS/TLS-Dependent Cytotoxicity
por: Ju, Shulin, et al.
Publicado: (2011) -
Non-Genomic Actions of the Androgen Receptor in Prostate Cancer
por: Leung, Jacky K., et al.
Publicado: (2017) -
Inhibition of androgen receptor by decoy molecules delays progression to castration-recurrent prostate cancer
por: Myung, Jae-Kyung, et al.
Publicado: (2017) -
ALS mutations in TLS/FUS disrupt target gene expression
por: Coady, Tristan H., et al.
Publicado: (2015)